TY - JOUR
T1 - Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison
AU - Karki, Radha
AU - Park, Chanmi
AU - Jun, Kyu Yeon
AU - Kadayat, Tara Man
AU - Lee, Eung Seok
AU - Kwon, Youngjoo
N1 - Publisher Copyright:
© 2014 Elsevier Masson SAS.
PY - 2015/1/27
Y1 - 2015/1/27
N2 - Dihydroxylated 2,4-diphenyl-6-aryl pyridine derivatives were simply achieved using Claisen-Schmidt condensation reaction and modified Kröhnke pyridine synthetic method. Total forty-five compounds were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of 2-and 4-phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel antitumor agents. Most of the prepared compounds exhibited significant antiproliferative activity on human cancer cell lines, HCT15 and K562, as well as potent topo II inhibitory activity comparable to or stronger than etoposide. The structure-activity relationship demonstrated that compounds with hydroxyl group at meta or para position of 2-phenyl ring in combination with hydroxyl at ortho, meta or para position of 4-phenyl ring displayed the most potent topoisomerase II inhibitory activity and cytotoxicity. Positive correlation between topoisomerase II inhibition and cytotoxicity was obtained for several compounds (30, 35, 36, 40-45, 49, 54, 56). Compound 56 showed the most potent topoisomerase II inhibitory activity at low concentration and functioned as a topoisomerase poison like the mode of action of etoposide.
AB - Dihydroxylated 2,4-diphenyl-6-aryl pyridine derivatives were simply achieved using Claisen-Schmidt condensation reaction and modified Kröhnke pyridine synthetic method. Total forty-five compounds were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of 2-and 4-phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel antitumor agents. Most of the prepared compounds exhibited significant antiproliferative activity on human cancer cell lines, HCT15 and K562, as well as potent topo II inhibitory activity comparable to or stronger than etoposide. The structure-activity relationship demonstrated that compounds with hydroxyl group at meta or para position of 2-phenyl ring in combination with hydroxyl at ortho, meta or para position of 4-phenyl ring displayed the most potent topoisomerase II inhibitory activity and cytotoxicity. Positive correlation between topoisomerase II inhibition and cytotoxicity was obtained for several compounds (30, 35, 36, 40-45, 49, 54, 56). Compound 56 showed the most potent topoisomerase II inhibitory activity at low concentration and functioned as a topoisomerase poison like the mode of action of etoposide.
KW - Antitumor agents
KW - Cytotoxicity
KW - Dihydroxylated 2 4-diphenyl-6-aryl
KW - Terpyridine bioisosteres
KW - Topoisomerase poison
KW - pyridine
UR - http://www.scopus.com/inward/record.url?scp=84913582122&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2014.11.045
DO - 10.1016/j.ejmech.2014.11.045
M3 - Article
C2 - 25437622
AN - SCOPUS:84913582122
SN - 0223-5234
VL - 90
SP - 360
EP - 378
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
ER -